Home Spirometry in Primary Care: an Implementation Study (Spiro@Home)

General Practitioners Research Institute

Status: Completed

Conditions: COPD Asthma

Treatments: Device: NuvoAir platform

Study type: Observational

Funder types: NETWORK

Identifiers

NCT05162157

GPRI-21003-SPI

Details and patient eligibility

About

Rationale: Spirometry is essential in the diagnosis of airway disease and can be useful in monitoring patients. Despite the essential role, spirometry remains largely underused in primary care. Due to Coronavirus disease (COVID-19), the use of office spirometry is contraindicated in many countries. Furthermore, spirometric devices are costly and personnel requires special training. Referral for spirometry increases the cost for patients and lowers the feasibility. Part of the reason for underdiagnosis of airway disease are the specific situations (such as exercise-induced asthma) in which spirometry in office setting might not reveal abnormalities. In recent years, handheld spirometry linked to phones/apps has been developed for study purposes and remote monitoring.

Objective: To study the feasibility, quality and added value of at-home spirometry for the diagnosis and monitoring of asthma and Chronic Obstructive Pulmonary Disease (COPD) in primary care.

Enrollment: 144 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 16 years
• Spirometry indication
• Able and willing to use at-home spirometry

Exclusion criteria

• On the discretion of the recruiting clinician if he or she deems a patient not eligible.
• Inability to understand and sign the informed consent form
• Known previous inability to perform spirometry
• Contraindications to perform spirometry as listed in the standardization of Spirometry 2019 update (Graham et al., 2019)

Trial design

144 participants in 1 patient group

at-home spirometry

Description:

This group performs spirometry at home with the Nuvoair spirometer

Treatment:

Device: NuvoAir platform